vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and DONEGAL GROUP INC (DGICA). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($270.7M vs $236.0M, roughly 1.1× DONEGAL GROUP INC). BALCHEM CORP runs the higher net margin — 14.9% vs 4.9%, a 10.0% gap on every dollar of revenue. On growth, BALCHEM CORP posted the faster year-over-year revenue change (8.1% vs -3.7%). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (7.5% CAGR vs -2.2%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Donegal Group Inc. is a regional US insurance holding company offering personal and commercial property and casualty insurance products. It serves Mid-Atlantic, Midwest, and Southern US customers, delivering tailored coverage for individuals, families, and small to medium businesses.
BCPC vs DGICA — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.7M | $236.0M |
| Net Profit | $40.3M | $11.5M |
| Gross Margin | — | — |
| Operating Margin | 20.5% | — |
| Net Margin | 14.9% | 4.9% |
| Revenue YoY | 8.1% | -3.7% |
| Net Profit YoY | 8.7% | -54.3% |
| EPS (diluted) | $1.25 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $270.7M | $236.0M | ||
| Q4 25 | $263.6M | $239.8M | ||
| Q3 25 | $267.6M | $245.9M | ||
| Q2 25 | $255.5M | $247.1M | ||
| Q1 25 | $250.5M | $245.2M | ||
| Q4 24 | $240.0M | $250.0M | ||
| Q3 24 | $239.9M | $251.7M | ||
| Q2 24 | $234.1M | $246.8M |
| Q1 26 | $40.3M | $11.5M | ||
| Q4 25 | $39.2M | $17.2M | ||
| Q3 25 | $40.3M | $20.1M | ||
| Q2 25 | $38.3M | $16.9M | ||
| Q1 25 | $37.1M | $25.2M | ||
| Q4 24 | $33.6M | $24.0M | ||
| Q3 24 | $33.8M | $16.8M | ||
| Q2 24 | $32.1M | $4.2M |
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — |
| Q1 26 | 20.5% | — | ||
| Q4 25 | 19.8% | 8.7% | ||
| Q3 25 | 20.4% | 10.2% | ||
| Q2 25 | 20.1% | 8.3% | ||
| Q1 25 | 20.4% | 12.7% | ||
| Q4 24 | 19.8% | 11.9% | ||
| Q3 24 | 20.0% | 8.1% | ||
| Q2 24 | 19.6% | 2.0% |
| Q1 26 | 14.9% | 4.9% | ||
| Q4 25 | 14.9% | 7.2% | ||
| Q3 25 | 15.1% | 8.2% | ||
| Q2 25 | 15.0% | 6.8% | ||
| Q1 25 | 14.8% | 10.3% | ||
| Q4 24 | 14.0% | 9.6% | ||
| Q3 24 | 14.1% | 6.7% | ||
| Q2 24 | 13.7% | 1.7% |
| Q1 26 | $1.25 | — | ||
| Q4 25 | $1.21 | — | ||
| Q3 25 | $1.24 | — | ||
| Q2 25 | $1.17 | — | ||
| Q1 25 | $1.13 | — | ||
| Q4 24 | $1.03 | — | ||
| Q3 24 | $1.03 | — | ||
| Q2 24 | $0.98 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $649.1M |
| Total Assets | $1.7B | $2.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $72.9M | — | ||
| Q4 25 | $74.6M | — | ||
| Q3 25 | $65.1M | — | ||
| Q2 25 | $65.4M | — | ||
| Q1 25 | $49.9M | — | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $73.7M | — | ||
| Q2 24 | $63.7M | — |
| Q1 26 | $1.3B | $649.1M | ||
| Q4 25 | $1.3B | $640.4M | ||
| Q3 25 | $1.3B | $627.4M | ||
| Q2 25 | $1.3B | $605.7M | ||
| Q1 25 | $1.2B | $584.7M | ||
| Q4 24 | $1.1B | $545.8M | ||
| Q3 24 | $1.2B | $513.4M | ||
| Q2 24 | $1.1B | $484.1M |
| Q1 26 | $1.7B | $2.4B | ||
| Q4 25 | $1.7B | $2.4B | ||
| Q3 25 | $1.7B | $2.4B | ||
| Q2 25 | $1.7B | $2.4B | ||
| Q1 25 | $1.6B | $2.4B | ||
| Q4 24 | $1.6B | $2.3B | ||
| Q3 24 | $1.6B | $2.3B | ||
| Q2 24 | $1.6B | $2.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $40.1M | — |
| Free Cash FlowOCF − Capex | $33.8M | — |
| FCF MarginFCF / Revenue | 12.5% | — |
| Capex IntensityCapex / Revenue | 2.3% | — |
| Cash ConversionOCF / Net Profit | 0.99× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $40.1M | — | ||
| Q4 25 | $67.3M | $70.2M | ||
| Q3 25 | $65.6M | $22.4M | ||
| Q2 25 | $47.3M | $12.1M | ||
| Q1 25 | $36.5M | $25.7M | ||
| Q4 24 | $52.3M | $67.4M | ||
| Q3 24 | $51.3M | $12.7M | ||
| Q2 24 | $45.0M | $21.7M |
| Q1 26 | $33.8M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 12.5% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 2.3% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.72× | 4.08× | ||
| Q3 25 | 1.63× | 1.11× | ||
| Q2 25 | 1.23× | 0.72× | ||
| Q1 25 | 0.98× | 1.02× | ||
| Q4 24 | 1.56× | 2.81× | ||
| Q3 24 | 1.52× | 0.76× | ||
| Q2 24 | 1.40× | 5.22× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
